Portola Valley, California, United States Three Arch Partners appeared to be the VC, which was created in 1993. The company was established in North America in United States. The leading representative office of defined VC is situated in the Portola Valley.
This organization was formed by Thomas Fogarty, Wilfred Jaeger. We also calculated 2 valuable employees in our database.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Three Arch Partners, startups are often financed by InterWest Partners, Investor Growth Capital Limited, New Leaf Venture Partners. The meaningful sponsors for the fund in investment in the same round are Polaris Partners, Investor Growth Capital Limited, Frazier Healthcare Partners. In the next rounds fund is usually obtained by Accuitive Medical Ventures, Polaris Partners, Investor Growth Capital Limited.
The average startup value when the investment from Three Arch Partners is 10-50 millions dollars. Considering the real fund results, this VC is 2 percentage points less often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2014. The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2007. This Three Arch Partners works on 2 percentage points less the average amount of lead investments comparing to the other organizations.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Biotechnology, Health Diagnostics. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline AcuFocus, Cameron Health, Arbor Surgical Technologies
Related Funds
Funds with similar focus
| Fund Name | Location |
| Accolade Partners | District of Columbia, United States, Washington |
| Acrobator Ventures | Acrobator.vc | Amsterdam, Noord-Holland, The Netherlands |
| Altamira Management | Canada, Ontario, Toronto |
| Besunyen (Beijing Outsell Health) | China, Guangdong, Wanchai |
| Digital Healthcare Partners | - |
| Financial Times | England, London, United Kingdom |
| Huayi Fangying | Beijing, Beijing, China |
| Invertec | Fairford, Gloucestershire, United Kingdom |
| Lever VC | New York, New York, United States |
| Masters Capital Management | Atlanta, Georgia, United States |
| Miracele China Investment Group | China, Futian, Guangdong |
| Mitani Sangyo | Ishikawa Prefecture, Japan, Kanazawa |
| Octava Foundation | - |
| Royalty Ventures | Bengaluru, India, Karnataka |
| S Capital VC | Israel, Tel Aviv, Tel Aviv |
| Sutton Capital | New York, New York, United States |
| Thrivent Financial | Minneapolis, Minnesota, United States |
| Venturelab | England, Leeds, United Kingdom |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Nevro | $48M | 07 Mar 2013 | California, United States | ||
Inova Labs | $17M | 08 Nov 2011 | Austin, Texas, United States | ||
Salveo Specialty Pharmacy | 13 Oct 2011 | Saint Petersburg, Florida, United States | |||
Nevro | $58M | 19 Jul 2011 | California, United States | ||
Crux Biomedical | $12M | 07 Jun 2011 | California, United States | ||
Tibion Bionic Technologies | $10M | 01 Mar 2011 | California, United States | ||
Respicardia | $27M | 25 Aug 2010 | Minnesota, United States | ||
Calistoga Pharmaceuticals | $40M | 30 Jun 2010 | Seattle, Washington, United States | ||
Baxano | $30M | 23 Jun 2010 | San Jose, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Nevro | $48M | 07 Mar 2013 | California, United States | ||
Inova Labs | $17M | 08 Nov 2011 | Austin, Texas, United States | ||
Salveo Specialty Pharmacy | 13 Oct 2011 | Saint Petersburg, Florida, United States | |||
Nevro | $58M | 19 Jul 2011 | California, United States | ||
Crux Biomedical | $12M | 07 Jun 2011 | California, United States | ||
Tibion Bionic Technologies | $10M | 01 Mar 2011 | California, United States | ||
Respicardia | $27M | 25 Aug 2010 | Minnesota, United States | ||
Calistoga Pharmaceuticals | $40M | 30 Jun 2010 | Seattle, Washington, United States | ||
Baxano | $30M | 23 Jun 2010 | San Jose, California, United States |
